Antimicrobial Evaluation of Nadifloxacin (OPC-7251), a New Topical Quinolone, in Acne Vulgaris
In Vitro and In Vivo Antibacterial Activity
- 12 Downloads
KeywordsMinimum Inhibitory Concentration Adis International Limited Acne Minimum Inhibitory Concen Fusidic Acid
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- 3.Kawabata S, Ohguro K, Mukai F, et al. Bacteriological evaluation of OPC-7251, a new pyridone caboxylic acid antimicrobial agent. I. In vitro antibacterial activity. Jpn J Chemother 1989; 37: 1160–78Google Scholar
- 4.Kawabata S, Masada H, Wakebe H, et al. Bacteriological evaluation of OPC-7251, a new pyridone carboxylic acid antimicrobial agent. II. Therapeutic effect of OPC-7251 cream on experimental infection model in mice. Jpn J Chemother 1989; 37: 1179–83Google Scholar
- 5.Eady EA, Ross JI, Cove JH, et al. The effects of oral erythromycin therapy for acne on the development of resistance in cutaneous staphylococci and propionibacteria In: Marks R, Plewig G, editors. Acne and related disorders. London: Martin Dunitz, 1989: 265–70Google Scholar
© Adis International Limited 1995